Among the most significantly over-represented pathways, we identified some involved in cancer, such as FoxO signaling pathway, signaling by Receptor Tyrosine Kinases, and PI3K-Akt signaling pathway (Fig. 2). This evidence concerns the gene NTRK1 and cancer.